These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial. Llorens P; Miró Ò; Herrero P; Martín-Sánchez FJ; Jacob J; Valero A; Alonso H; Pérez-Durá MJ; Noval A; Gil-Román JJ; Zapater P; Llanos L; Gil V; Perelló R Emerg Med J; 2014 Sep; 31(9):706-13. PubMed ID: 23793945 [TBL] [Abstract][Full Text] [Related]
3. Which dosing of furosemide is better in acute decompensated heart failure? Jalaba S; Palermo J; Budavari AI JAAPA; 2017 Mar; 30(3):11-12. PubMed ID: 28221314 [TBL] [Abstract][Full Text] [Related]
4. Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. Ng TM; Hshieh S; Chan CY; Elkayam U J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):373-81. PubMed ID: 22610091 [TBL] [Abstract][Full Text] [Related]
5. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance. Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC; J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154 [TBL] [Abstract][Full Text] [Related]
6. Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study. Matsue Y; Suzuki M; Nagahori W; Yoshida K; Onishi Y; Satoh Y; Ono Y; Nishioka T; Noda M; Sugi K; Torii S; Tejima T; Sakurada H; Yamaguchi S; Okishige K; Fujii H; Takahashi A Cardiovasc Drugs Ther; 2014 Feb; 28(1):73-7. PubMed ID: 24048511 [TBL] [Abstract][Full Text] [Related]
7. Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis. Matsue Y; Shiraishi A; Kagiyama N; Yoshida K; Kume T; Okura H; Suzuki M; Matsumura A; Yoshida K; Hashimoto Y Heart Vessels; 2016 Dec; 31(12):1980-1987. PubMed ID: 26892531 [TBL] [Abstract][Full Text] [Related]
8. Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. Niu X; Yang C; Yao Y Int J Cardiol; 2014 Sep; 176(1):288. PubMed ID: 25042652 [No Abstract] [Full Text] [Related]
9. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Sancho-Zamora MA Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):241-2. PubMed ID: 24774406 [No Abstract] [Full Text] [Related]
10. Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect! de Grooth HJ; Girbes AR; Tuinman PR Crit Care; 2014 Dec; 18(6):709. PubMed ID: 25672666 [No Abstract] [Full Text] [Related]
11. Reply: Comments on hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. Gandhi S; Mosleh W; Myers RB Int J Cardiol; 2014 Oct; 176(3):1153. PubMed ID: 25125011 [No Abstract] [Full Text] [Related]
12. Home subcutaneous infusion of furosemide in advanced decompensated heart failure. Response. Zatarain-Nicolás E; de la Fuente-Galán L; San Román-Calvar JA Rev Esp Cardiol (Engl Ed); 2014 Mar; 67(3):242. PubMed ID: 24774407 [No Abstract] [Full Text] [Related]
13. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113 [TBL] [Abstract][Full Text] [Related]
14. Diuretic strategies in patients with acute heart failure. Jenkins PG N Engl J Med; 2011 May; 364(21):2066; author reply 2069. PubMed ID: 21612482 [No Abstract] [Full Text] [Related]
15. Hypertonic saline with furosemide for diuretic resistant congestive heart failure in an infant. Shiraishi M; Murakami T; Nawa T; Kobayashi H; Nagamine H; Shiraga K; Higashi K; Nakajima H Int J Cardiol; 2016 Jul; 215():127-8. PubMed ID: 27111174 [No Abstract] [Full Text] [Related]
16. Subcutaneous furosemide in patients with refractory heart failure. Lozano Bahamonde A; Escolar Pérez V; Laskibar Asua A; Rodríguez Rodríguez M; Murga Eizagaechevarria N BMJ Support Palliat Care; 2018 Sep; 8(3):354-355. PubMed ID: 29903849 [No Abstract] [Full Text] [Related]
17. Diuretic strategies in patients with acute heart failure. Llorens P; Herrero P; Miró Ò N Engl J Med; 2011 May; 364(21):2068-9; author reply 2069. PubMed ID: 21612478 [No Abstract] [Full Text] [Related]
18. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure. Pivac N; Rumboldt Z; Sardelić S; Bagatin J; Polić S; Ljutić D; Naranca M; Capkun V Int J Clin Pharmacol Res; 1998; 18(3):121-8. PubMed ID: 9825268 [TBL] [Abstract][Full Text] [Related]
19. Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure. Picazo Sánchez M; Castillo Lorenzo MN; Cuxart Pérez M; Sans Lorman R Nefrologia (Engl Ed); 2018; 38(4):438-439. PubMed ID: 29275931 [No Abstract] [Full Text] [Related]
20. Dopamine in acute decompensated heart failure: does left ventricular ejection fraction matter? Dalzell JR; Connolly EC Int J Cardiol; 2014 Jul; 174(3):739. PubMed ID: 24767136 [No Abstract] [Full Text] [Related] [Next] [New Search]